{
  "id": 8051233,
  "title": "Cancer biologists bring in the B-cell reinforcements for immunotherapy",
  "url": "https://urgent.news/2026/09/17/cancer-biologists-bring-in-the-b-cell-reinforcements-for-immunotherapy",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-17T16:00:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-cancer-biologists-cell-immunotherapy.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Cancer biologists are exploring the potential of B cells to enhance the effectiveness of immunotherapy in treating cancer. While T cells have been the focus of immunotherapy, not all patients respond well to standard-of-care T cell immunotherapies. Salk Institute scientist Daniel Hollern and his team have discovered that B cells play a crucial role in promoting T cell antitumor activity. Their study, published in Cell Reports, shows that B cells can regulate killer T cell function, prompting these cells into tumors, organize them, and enhance their cytotoxic function. This new understanding of B cells' role in cancer immunotherapy could revolutionize cancer care, providing a more effective treatment option for patients who do not respond to traditional therapies.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}